W
WAVEMAN · COMPANY
BDX · Becton Dickinson & Co
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

BDX

BECTON DICKINSON & CO
MEDICAL DEVICES · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS · CIK 0000010795
FORM 144 · 8☆ WATCH
INSIDER NET · 180D
-$2.0M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
688
13F, latest reported quarter
REVENUE GROWTH
+8.2%
XBRL, annual
NET MARGIN
7.7%
CONVERSIONS · 180D
2
codes C/M, not in net · $9.8M priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$2.0M over 180 days
-$1.6M over 90 days
below 65% of Medical Devices
CONGRESS
no member of Congress has reported trading it
FUNDS
688 funds added or opened last quarter
more than 94% of Medical Devices
REVENUE
+8.2% year over year
more than 51% of Medical Devices
MARGIN
7.7% net margin
more than 73% of Medical Devices
BUYBACKS
$2.2B repurchased, FY to 2026-06-30
more than 96% of Medical Devices
SHORT
3.7% of shares outstanding short · 5.7 days to cover · settled 2026-07-31
more than 52% of Medical Devices
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$2.0M across 4 people in 180 days.
688 funds added or opened positions in the latest 13F quarter, of 1,440 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +28.0%
+28.0%12M
-6%+7%+20%+33%2025-092025-102025-122026-032026-052026-072026-09 2026-08-13 · Polen Thomas E Jr sold $768.1K2026-08-11 · Goette Roland sold $440.9K2026-06-01 · Polen Thomas E Jr sold $404.5K2026-01-15 · Garrison Michael David sold $208.6K2026-02-18 · SCOTT BERTRAM L sold $174.0K2025-09-10 · Fraser Claire sold $171.9K2026-06-10 · Garrison Michael David sold $166.6K2026-06-24 · Garrison Michael David sold $160.2K2026-01-15 · Garrison Michael David sold $125.4K2025-12-17 · Garrison Michael David sold $123.3K2025-11-07 · SCOTT BERTRAM L sold $38.3K2026-08-26 · Feld Michael sold $31.1K2026-01-26 · Feld Michael sold $15.2K2025-12-26 · Feld Michael sold $14.5K2025-12-01 · Feld Michael sold $14.5K2026-02-26 · Feld Michael sold $13.6K2026-07-27 · Feld Michael sold $11.8K2026-03-26 · Feld Michael sold $11.8K2026-06-26 · Feld Michael sold $11.5K2026-04-27 · Feld Michael sold $11.2K2026-05-26 · Feld Michael sold $11.1K2025-10-27 · Feld Michael sold $10.6K2025-09-26 · Feld Michael sold $10.5K2026-08-26 · MICHAEL FELD filed to sell $31.3K2026-08-20 · RICHARD BYRD filed to sell $250.0K2026-08-13 · THOMAS POLEN filed to sell $762.2K2026-08-11 · Roland Goette filed to sell $440.9K2026-08-03 · SHANA NEAL filed to sell $248.4K2026-07-27 · MICHAEL FELD filed to sell $11.7K2026-06-26 · MICHAEL FELD filed to sell $11.4K2026-06-24 · MICHAEL GARRISON filed to sell $158.3K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $2.0M sold by insiders over 180 days, 688 funds added last quarter, $1.9M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, BECTON DICKINSON & CO insiders sold a net $2.0M of stock across 89 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Feld Michael
EVP, Chief Revenue Officer
SELL
2026-08-26
165.0
$31.1K
Polen Thomas E Jr
Chairman, CEO and President
SELL
2026-08-13
4,152.0
$768.1K
Goette Roland
EVP and President, EMEA
SELL
2026-08-11
2,438.0
$440.9K
Feld Michael
EVP, Chief Revenue Officer
SELL
2026-07-27
75.0
$11.8K
Feld Michael
EVP, Chief Revenue Officer
SELL
2026-06-26
75.0
$11.5K
89 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 84 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
First Eagle Investment Management, LLC
27,630,670.0 sh
$4.2B
BlackRock, Inc.
24,592,166.0 sh
$3.7B
VANGUARD CAPITAL MANAGEMENT LLC
17,987,834.0 sh
$2.7B
MASSACHUSETTS FINANCIAL SERVICES CO /MA/
8,650,967.0 sh
$2.5B
STATE STREET CORP
15,000,064.0 sh
$2.3B
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
MICHAEL FELD
FILED 2026-08-26
$31.3K
RICHARD BYRD
FILED 2026-08-20
$250.0K
THOMAS POLEN
FILED 2026-08-13
$762.2K
Roland Goette
FILED 2026-08-11
$440.9K
SHANA NEAL
FILED 2026-08-03
$248.4K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Clarkston Fund
$4.9M POSITION · AS OF 2026-03-31
5.0%
Oakmark Global Select Fund
$41.2M POSITION · AS OF 2026-03-31
4.7%
FMI Large Cap Fund
$51.1M POSITION · AS OF 2026-03-31
4.6%
iShares U.S. Medical Devices ETF
$145.1M POSITION · AS OF 2026-03-31
4.6%
LONE PEAK VALUE FUND
$5.6M POSITION · AS OF 2026-03-31
3.9%
FMI Global Fund
$397.0K POSITION · AS OF 2026-03-31
3.7%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Executive pay vs shareholder return · Thomas E. Polen
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$17.1M
$3.5M
$4.3M
-11%
+30%
2024
$17.3M
$9.5M
$4.0M
+13%
+27%
2023
$17.3M
$29.8M
$4.5M
+19%
+2%
2022
$16.7M
$15.0M
$4.2M
+1%
-10%
2021
$14.2M
$16.7M
$3.7M
+7%
+27%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-092024-092023-092022-09
REVENUE$21.8B$20.2B$19.4B$18.9B
OPERATING INCOME$2.6B$2.4B$2.1B$2.3B
NET INCOME$1.7B$1.7B$1.5B$1.8B
EPS (DILUTED)5.825.864.945.88
CASH$641.0M$1.7B$1.4B$1.0B
LONG-TERM DEBT$17.6B$17.9B$14.7B$13.9B
BUYBACKS$1.0B$500.0M$0$500.0M
DIVIDENDS PAID$1.2B$1.1B$1.1B$1.1B
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →